Outperform Votes

Underperform Votes

Community Sentiment

Orthopediatrics has received 50.28% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote “Outperform” if you believe KIDS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.0 Company Ownership

In the past three months, Orthopediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $753,613.00 in company stock.

Miscellaneous

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

How has Orthopediatrics' stock been impacted by COVID-19 (Coronavirus)?

Orthopediatrics' stock was trading at $39.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, KIDS stock has increased by 21.4% and is now trading at $48.26. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthopediatrics.

When is Orthopediatrics' next earnings date?

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) issued its earnings results on Tuesday, May, 5th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.25) by $0.05. The firm earned $16.36 million during the quarter, compared to analyst estimates of $16.95 million. Orthopediatrics had a negative net margin of 21.08% and a negative return on equity of 12.26%. View Orthopediatrics' earnings history.

What price target have analysts set for KIDS?

6 brokers have issued 12 month price targets for Orthopediatrics' shares. Their forecasts range from $48.00 to $54.00. On average, they anticipate Orthopediatrics' stock price to reach $49.83 in the next twelve months. This suggests a possible upside of 3.3% from the stock's current price. View analysts' price targets for Orthopediatrics.

Has Orthopediatrics been receiving favorable news coverage?

News articles about KIDS stock have trended extremely negative on Sunday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Orthopediatrics earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news aboutOrthopediatrics.

Are investors shorting Orthopediatrics?

Orthopediatrics saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,840,000 shares, an increase of 11.5% from the April 30th total of 1,650,000 shares. Based on an average daily volume of 139,100 shares, the days-to-cover ratio is currently 13.2 days. Currently, 16.0% of the shares of the stock are short sold. View Orthopediatrics' Current Options Chain.

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

Which major investors are selling Orthopediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Wasatch Advisors Inc., Squarepoint Ops LLC, Burrage Capital Management LLC, Scholtz & Company LLC, Invesco Ltd., UBS Group AG, and Ensign Peak Advisors Inc. Company insiders that have sold Orthopediatrics company stock in the last year include Bernie B Berry III, David R Bailey, Gregory A Odle, Mark C Throdahl, and Stephen F Burns. View insider buying and selling activity for Orthopediatrics.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $48.26.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $859.99 million and generates $72.55 million in revenue each year. The company earns $-13,730,000.00 in net income (profit) each year or ($0.87) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.